Effects of coronary stents on cardiovascular outcomes in broad-based clinical practice

S E Kimmel1, A R Localio, C Brensinger

  • 1University of Pennsylvania School of Medicine, Center for Clinical Epidemiology and Biostatistics, 717 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104-6021,USA. skimmel@cceb.med.upenn.edu

Insights

Coronary stents reduce the need for repeat procedures in real-world practice, confirming trial results. However, this study found no impact on subsequent heart attack or cardiac death rates.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • Randomized trials show coronary stents reduce repeat percutaneous coronary intervention (PCI).
  • Real-world effectiveness of stents in diverse clinical practice remains understudied.
  • Impact of stents on myocardial infarction and cardiac death requires further investigation.

Purpose of the Study:

  • To evaluate the effectiveness of coronary stents in reducing repeat PCI procedures in a broad clinical setting.
  • To assess the impact of stents on in-hospital events, revascularization rates, and subsequent myocardial infarction or cardiac death.
  • To compare stent outcomes with non-stent procedures in a large patient cohort.

Main Methods:

  • Retrospective cohort study using the Pennsylvania Health Care Cost Containment Council database.
  • Included 5258 patients undergoing PCI across 43 hospitals in late 1995.
  • Primary outcomes: in-hospital events (death/coronary bypass), 6-month revascularization, and 6-month cardiac death/myocardial infarction.

Main Results:

  • Stent use (24% of patients) significantly reduced in-hospital events, primarily coronary bypass surgery (52% reduction).
  • Stents decreased the need for follow-up revascularization, including a 31% reduction in repeated PCI.
  • No significant effect of stents was observed on 6-month rates of myocardial infarction or cardiac death.

Conclusions:

  • Coronary stents effectively decrease repeat PCI in broad clinical practice, aligning with randomized trial findings.
  • This study did not find evidence that stents reduce subsequent myocardial infarction or cardiac death.
  • Real-world data confirms stent benefits for procedural outcomes but highlights the need for continued research on long-term clinical endpoints.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...